For instance, oncogenic miRNAs (oncomiRs) such as the miR-17-92 cluster (including miR-17, miR-20a, etc.)drive aberrant cell cycle progression in small cell lung cancer (SCLC) by inhibiting the p21 and Rb signaling pathways [20,21]. This evidence concerns the gene RB1 and small cell lung carcinoma.